Angiology
Invasive MRI is feasible and apparently safe during peripheral angioplasty
Published in Cardiovascular Week, April 25th, 2005
According to scientists in the United States, "We tested the feasibility and safety of invasive magnetic resonance imaging (MRI) during peripheral angioplasty. Real-time MRI can image soft tissue and may potentially guide therapeutic procedures without ionizing radiation or nephrotoxic contrast."
A.J. Dick and colleagues of the U.S. National Institutes of Health continued, "MRI-guided diagnostic catheterization has been described recently, but safe and conspicuous catheter devices are not widely available. An...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2005-04-25)
More Articles from Cardiovascular Week
- Atherosclerosis
LRP1 plays a pathologic function during atherosclerotic lesion progression - Cardioprotection
Nonerythropoietic derivatives may be more effective for treating CV diseases - Hypertension
Majority of hypertensive patients will require combination therapy - Pulmonary Hypertension
Oxidant stress decreases with epoprostenol therapy - Acute Pulmonary Embolism
L-Arginine attenuates APE-induced pulmonary hypertension in rats - Adverse Drug Reaction
Thrombocytopenia can occur in patients receiving clopidogrel and aspirin - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
